688046 药康生物
已收盘 07-19 15:00:00
资讯
新帖
简况
药康生物最新公告:公司董事长提议中期分红
证券之星 · 07-17 17:31
药康生物最新公告:公司董事长提议中期分红
药康生物(688046.SH)实控人提议公司实施2024年中期分红
智通财经 · 07-17 17:26
药康生物(688046.SH)实控人提议公司实施2024年中期分红
药康生物大跌5.08% 北向资金减持13.52万股
智选洞察 · 07-15
药康生物大跌5.08% 北向资金减持13.52万股
药康生物涨5.12% 北向资金增持0.64万股
智选洞察 · 07-12
药康生物涨5.12% 北向资金增持0.64万股
药康生物大幅上涨 获北向资金增持18.64万股
智选洞察 · 07-11
药康生物大幅上涨 获北向资金增持18.64万股
药康生物大跌5.09% 创历史新低
智选洞察 · 07-08
药康生物大跌5.09% 创历史新低
药康生物07月05日主力资金流出50万元 连续3日减仓
自选股智能写手 · 07-05
药康生物07月05日主力资金流出50万元 连续3日减仓
药康生物:累计回购约152万股
每日经济新闻 · 07-01
药康生物:累计回购约152万股
药康生物6月28日转融通出借成交3600股
金融界 · 07-01
药康生物6月28日转融通出借成交3600股
药康生物(688046)6月27日主力资金净卖出69.85万元
证券之星 · 06-28
药康生物(688046)6月27日主力资金净卖出69.85万元
药康生物06月24日遭主力抛售63万元 环比增加472.73%
自选股智能写手 · 06-24
药康生物06月24日遭主力抛售63万元 环比增加472.73%
药康生物创近1月新低 近半年14家券商看好
智选洞察 · 06-24
药康生物创近1月新低 近半年14家券商看好
CRO概念盘中跳水,药康生物跌0.54%
自选股智能写手 · 06-19
CRO概念盘中跳水,药康生物跌0.54%
药康生物(688046.SH):目前老产能均处满产状态,新增产能按生产计划爬坡中
格隆汇资讯 · 06-18
药康生物(688046.SH):目前老产能均处满产状态,新增产能按生产计划爬坡中
北向资金6月14日净卖出药康生物29.91万股 连续3日减持
自选股智能写手 · 06-17
北向资金6月14日净卖出药康生物29.91万股 连续3日减持
药康生物:业绩说明会定于6月25日举行
每日经济新闻 · 06-14
药康生物:业绩说明会定于6月25日举行
CRO概念盘中拉升,药康生物涨0.50%
自选股智能写手 · 06-14
CRO概念盘中拉升,药康生物涨0.50%
药康生物:海外业务拓展成亮点 多家券商予以“买入”评级
中国财富通 · 06-12
药康生物:海外业务拓展成亮点 多家券商予以“买入”评级
药明生物大涨近15%,金斯瑞涨近5%!业内人士解释CRO拉升原因
格隆汇资讯 · 06-12
药明生物大涨近15%,金斯瑞涨近5%!业内人士解释CRO拉升原因
北向资金6月7日净卖出药康生物14.43万股 连续5日减持
自选股智能写手 · 06-11
北向资金6月7日净卖出药康生物14.43万股 连续5日减持
加载更多
公司概况
公司名称:
江苏集萃药康生物科技股份有限公司
所属行业:
研究和试验发展
上市日期:
2022-04-25
主营业务:
江苏集萃药康生物科技股份有限公司是一家专业从事实验动物小鼠模型的研发、生产、销售及相关技术服务的高新技术企业,主要产品有商品化小鼠模型销售业务、模型定制业务、定制繁育业务、功能药效业务、代理进出口及其他业务。公司为国内模式动物行业龙头企业之一,是亚洲小鼠突变和资源联盟唯一企业成员、国家科技资源共享服务平台(国家遗传工程小鼠资源库)共建单位,先后被认定为国家级高新技术企业、江苏省博士后创新实践基地、江苏省工程技术研究中心、国家级专精特新小巨人企业等。
发行价格:
22.53
{"stockData":{"symbol":"688046","market":"SH","secType":"STK","nameCN":"药康生物","latestPrice":10.36,"timestamp":1721372400000,"preClose":10.19,"halted":0,"volume":2211641,"delay":0,"floatShares":204000000,"shares":409999999,"eps":0.3838,"marketStatus":"已收盘","marketStatusCode":5,"change":0.17,"latestTime":"07-19 15:00:00","open":10.11,"high":10.45,"low":10.1,"amount":22815800,"amplitude":0.0343,"askPrice":10.37,"askSize":5,"bidPrice":10.36,"bidSize":152,"shortable":0,"etf":0,"ttmEps":0.3838,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":10.19,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721352600000,1721359800000],[1721365200000,1721372400000]],"highLimit":11.21,"lowLimit":9.17,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":410000000,"pbRate":1.99,"roa":"--","roe":"1.39%","epsLYR":0.39,"committee":-0.306011,"marketValue":4248000000,"floatMarketCap":2113000000,"peRate":26.993226,"changeRate":0.0167,"turnoverRate":0.0108,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-07-22。","afterMarket":{"amount":0,"volume":0,"close":10.36,"buyVolume":0,"sellVolume":0,"time":1721374439754,"indexStatus":"已收盘 07-19 15:30:00","preClose":10.19}},"requestUrl":"/m/hq/s/688046","defaultTab":"news","newsList":[{"id":"2452913516","title":"药康生物最新公告:公司董事长提议中期分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2452913516","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452913516?lang=zh_cn&edition=full","pubTime":"2024-07-17 17:31","pubTimestamp":1721208666,"startTime":"0","endTime":"0","summary":"药康生物公告,公司董事长、实际控制人高翔提议中期分红。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700036901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2452133407","title":"药康生物(688046.SH)实控人提议公司实施2024年中期分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2452133407","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452133407?lang=zh_cn&edition=full","pubTime":"2024-07-17 17:26","pubTimestamp":1721208387,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药康生物(688046.SH)发布公告,近日公司收到由公司董事长、实际控制人高翔出具的《关于提议中期分红暨落实公司2024年年度“提质增效重回报”行动方案的提议函》,提议:在符合《江苏集萃药康生物科技股份有限公司章程》规定的利润分配原则、保证公司正常经营和长远发展的前提下,制定并实施2024年中期分红方案,具体利润分配方案由公司结合自身经营情况并报董事会及股东大会审议确定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2451117698","title":"药康生物大跌5.08% 北向资金减持13.52万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451117698","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451117698?lang=zh_cn&edition=full","pubTime":"2024-07-15 13:20","pubTimestamp":1721020801,"startTime":"0","endTime":"0","summary":"07月15日,药康生物股价大幅下跌,截至13点20分,药康生物下跌5.08%,报9.71元/股,成交1849万元,换手率0.92%,振幅5.18%。资金动向截止发稿,药康生物获得主力净流出51万元。北向资金方面,药康生物07月12日获得北向资金减持13.52万股,截至07月12日,北向资金当前共持有药康生物121.79万股,市值1182万元,持股占流通股比为0.59%。最新财报显示,今年一季报,药康生物实现营业收入1.57亿元,同比增长11.96%,净利润为2,947.94万元,同比减少5.06%,基本每股收益为0.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715132016af924f6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715132016af924f6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2450186320","title":"药康生物涨5.12% 北向资金增持0.64万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450186320","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450186320?lang=zh_cn&edition=full","pubTime":"2024-07-12 13:15","pubTimestamp":1720761337,"startTime":"0","endTime":"0","summary":"07月12日,药康生物股价大幅上涨,截至13点15分,药康生物上涨5.12%,报10.27元/股,突破10元整数关口,成交3578万元,换手率1.75%,振幅4.81%。北向资金方面,药康生物07月11日获得北向资金增持0.64万股,截至07月11日,北向资金当前共持有药康生物135.30万股,市值1389万元,持股占流通股比为0.66%。最新财报显示,今年一季报,药康生物实现营业收入1.57亿元,同比增长11.96%,净利润为2,947.94万元,同比减少5.06%,基本每股收益为0.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712131549aef95d5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712131549aef95d5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2450087742","title":"药康生物大幅上涨 获北向资金增持18.64万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450087742","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450087742?lang=zh_cn&edition=full","pubTime":"2024-07-11 10:06","pubTimestamp":1720663578,"startTime":"0","endTime":"0","summary":"07月11日,药康生物股价大幅上涨,截至10点06分,药康生物上涨5.14%,报9.81元/股,成交849万元,换手率0.43%,振幅3.75%。资金动向截止发稿,药康生物获得主力净流入22万元。北向资金方面,药康生物07月10日获得北向资金增持18.64万股,截至07月10日,北向资金当前共持有药康生物134.66万股,市值1321万元,持股占流通股比为0.66%。最新财报显示,今年一季报,药康生物实现营业收入1.57亿元,同比增长11.96%,净利润为2,947.94万元,同比减少5.06%,基本每股收益为0.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711101100aef91a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711101100aef91a79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2449443227","title":"药康生物大跌5.09% 创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2449443227","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449443227?lang=zh_cn&edition=full","pubTime":"2024-07-08 14:41","pubTimestamp":1720420906,"startTime":"0","endTime":"0","summary":"07月08日,药康生物股价大幅下跌,截至14点41分,药康生物下跌5.09%,报9.32元/股,创历史新低,成交2055万元,换手率1.06%。资金动向截止发稿,药康生物获得主力净流出51万元。北向资金方面,药康生物07月05日获得北向资金增持23.41万股,截至07月05日,北向资金当前共持有药康生物117.43万股,市值1094万元,持股占流通股比为0.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708144159aef8609b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708144159aef8609b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2449232130","title":"药康生物07月05日主力资金流出50万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2449232130","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449232130?lang=zh_cn&edition=full","pubTime":"2024-07-05 15:18","pubTimestamp":1720163882,"startTime":"0","endTime":"0","summary":"07月05日, 药康生物股价涨3.26%,报收9.82元,成交金额2204万元,换手率1.12%,振幅5.05%,量比0.99。药康生物今日主力资金净流出50万元,连续3日净流出,上一交易日主力净流出203万元,今日环比减少75.37%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为70.59%,平均跌幅为1.82%。该股近5个交易日下跌3.91%,主力资金累计净流出760万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出1871万元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051525119f08da3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051525119f08da3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2448966168","title":"药康生物:累计回购约152万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448966168","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448966168?lang=zh_cn&edition=full","pubTime":"2024-07-01 16:36","pubTimestamp":1719822982,"startTime":"0","endTime":"0","summary":"每经AI快讯,药康生物 7月1日晚间发布公告称,截至2024年6月30日,公司通过上海证券交易所交易系统以集中竞价交易方式累计回购公司股份约152万股,占公司总股本4.1亿股的比例为0.3712%,回购成交的最高价为19.17元/股,最低价为11.89元/股,支付的资金总额为人民币约2386万元。2023年1至12月份,药康生物的营业收入构成为:科学研究和技术服务占比99.93%。截至发稿,药康生物市值为42亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701163649955daa71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701163649955daa71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2448980230","title":"药康生物6月28日转融通出借成交3600股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448980230","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448980230?lang=zh_cn&edition=full","pubTime":"2024-07-01 08:41","pubTimestamp":1719794485,"startTime":"0","endTime":"0","summary":"根据上交所网站显示,6月28日,药康生物转融通出借成交3600股,期限为10天。据了解,转融通是指证券金融公司将自有或者依法筹集的资金和证券出借给证券公司,以供其办理融资融券业务的经营活动。上交所接受借入人借入申报的时间为每个交易日9:15至11:30、13:00至15:10。公开资料显示,药康生物法人代表为赵静,公司注册资本4.1亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407010845199ee8c932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407010845199ee8c932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2446518579","title":"药康生物(688046)6月27日主力资金净卖出69.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446518579","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446518579?lang=zh_cn&edition=full","pubTime":"2024-06-28 08:20","pubTimestamp":1719534025,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月27日收盘,药康生物报收于10.47元,下跌4.3%,换手率1.13%,成交量2.3万手,成交额2443.82万元。近5日资金流向一览见下表:药康生物融资融券信息显示,融资方面,当日融资买入168.11万元,融资偿还75.43万元,融资净买入92.68万元。药康生物主营业务:实验动物模型的研发创制、生产销售及相关技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800013499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2445004607","title":"药康生物06月24日遭主力抛售63万元 环比增加472.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445004607","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445004607?lang=zh_cn&edition=full","pubTime":"2024-06-24 15:17","pubTimestamp":1719213479,"startTime":"0","endTime":"0","summary":"06月24日, 药康生物股价跌4.72%,报收10.70元,成交金额4800万元,换手率2.17%,振幅5.16%,量比1.22。药康生物今日主力资金净流出63万元,连续3日净流出,上一交易日主力净流出11万元,今日环比增加472.73%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为68.75%,平均跌幅为1.86%。该股近5个交易日下跌7.76%,主力资金累计净流出505万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出963万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241525519f5ec17d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241525519f5ec17d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2445084090","title":"药康生物创近1月新低 近半年14家券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2445084090","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445084090?lang=zh_cn&edition=full","pubTime":"2024-06-24 10:35","pubTimestamp":1719196546,"startTime":"0","endTime":"0","summary":"06月24日,药康生物股价大幅下跌,截至10点35分,药康生物下跌5.08%,报10.66元/股,创近1月新低,成交1743万元,换手率0.78%,振幅4.81%。北向资金方面,药康生物06月21日获得北向资金增持6.83万股,截至06月21日,北向资金当前共持有药康生物143.24万股,市值1526万元,持股占流通股比为0.70%。最新财报显示,今年一季报,药康生物实现营业收入1.57亿元,同比增长11.96%,净利润为2,947.94万元,同比减少5.06%,基本每股收益为0.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624105247af8ecf43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624105247af8ecf43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2444977404","title":"CRO概念盘中跳水,药康生物跌0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444977404","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444977404?lang=zh_cn&edition=full","pubTime":"2024-06-19 10:20","pubTimestamp":1718763659,"startTime":"0","endTime":"0","summary":"06月19日,CRO概念盘中跳水,截至10点20分,CRO概念整体指数下跌1.03%,报336.880点。从个股上来看,该概念的成分股中,药康生物跌0.54%,泰格医药、义翘神州、和元生物跌幅居前。从资金上来看,截止发稿,CRO概念主力净流入为-1.22亿,其中泰格医药受到资金热捧,主力净流入658.22万;拉长时间线来看,该板块近20日主力资金净流入-46.60亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061910205996815104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061910205996815104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046","03347"],"gpt_icon":0},{"id":"2444084681","title":"药康生物(688046.SH):目前老产能均处满产状态,新增产能按生产计划爬坡中","url":"https://stock-news.laohu8.com/highlight/detail?id=2444084681","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444084681?lang=zh_cn&edition=full","pubTime":"2024-06-18 16:01","pubTimestamp":1718697661,"startTime":"0","endTime":"0","summary":"格隆汇6月18日丨药康生物(688046.SH)在投资者互动平台表示,公司在江苏南京、江苏常州、广东佛山、四川成都、北京大兴、上海宝山运营七个大型生产设施,合计产能约 28 万笼,其中8万笼为2023年新增产能,目前老产能均处满产状态,新增产能按生产计划爬坡中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181601069f498b7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181601069f498b7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2444885571","title":"北向资金6月14日净卖出药康生物29.91万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2444885571","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444885571?lang=zh_cn&edition=full","pubTime":"2024-06-17 09:30","pubTimestamp":1718587840,"startTime":"0","endTime":"0","summary":"6月14日,北向资金减持药康生物29.91万股连续3日减持。截止当日收盘,沪股通共持有药康生物122.00万股,占流通股0.59%。沪股通减持金额前五个股分别为长江电力、药明康德、交通银行、晶科能源、佰维存储。药康生物近5个交易日上涨3.16%,沪股通累计减持38.22万股;近20个交易日上涨2.53%,沪股通累计减持123.20万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061709363495b7c13c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061709363495b7c13c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2443164985","title":"药康生物:业绩说明会定于6月25日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2443164985","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443164985?lang=zh_cn&edition=full","pubTime":"2024-06-14 16:57","pubTimestamp":1718355445,"startTime":"0","endTime":"0","summary":"每经AI快讯,药康生物 6月14日晚间发布公告称,公司2023年度暨2024年第一季度业绩说明会定于2024年06月25日下午15:00-16:00,以上证路演中心网络互动的形式进行。2023年1至12月份,药康生物的营业收入构成为:科学研究和技术服务占比99.93%。截至发稿,药康生物市值为48亿元。道达号“个股趋势”提醒:1. 药康生物近30日内北向资金持股量减少61.22万股,占流通股比例减少0.30%;2. 近30日内无机构对药康生物进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406141658049f3c524a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406141658049f3c524a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2443515696","title":"CRO概念盘中拉升,药康生物涨0.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443515696","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443515696?lang=zh_cn&edition=full","pubTime":"2024-06-14 11:18","pubTimestamp":1718335091,"startTime":"0","endTime":"0","summary":"06月14日,CRO概念盘中拉升,截至11点18分,CRO概念整体指数上涨0.54%,报344.710点。从个股上来看,该概念的成分股中,药康生物涨0.50%,涨幅居前。从资金上来看,截止发稿,CRO概念主力净流入为-4.34亿,其中美迪西受到资金热捧,主力净流入598.11万;拉长时间线来看,该板块近20日主力资金净流入-43.76亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614111811af8d8840&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614111811af8d8840&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2442557581","title":"药康生物:海外业务拓展成亮点 多家券商予以“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2442557581","media":"中国财富通","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442557581?lang=zh_cn&edition=full","pubTime":"2024-06-12 16:06","pubTimestamp":1718179561,"startTime":"0","endTime":"0","summary":"近期的数份券商研报显示,药康生物持续增加研发投入,新品新项目顺利推进;海外市场拓展加速,或成业绩增长亮点。考虑到药康生物目前估值处于较低水平,看好公司业绩持续修复及后续投资价值。海外业务增长可期分析人士指出,药康生物处于业务扩张阶段,在国内外加速业务布局及拓展,尤其是公司的海外业务进展被多家券商看好。此外,药康生物国内业务及市场开拓亦在稳步推进中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=5HWcuqIN7g0%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688046"],"gpt_icon":0},{"id":"2442864308","title":"药明生物大涨近15%,金斯瑞涨近5%!业内人士解释CRO拉升原因","url":"https://stock-news.laohu8.com/highlight/detail?id=2442864308","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442864308?lang=zh_cn&edition=full","pubTime":"2024-06-12 11:38","pubTimestamp":1718163524,"startTime":"0","endTime":"0","summary":"港A两地CRO板块集体拉升,其中,港股市场药明生物大涨近15%,药明康德涨9%,康龙化成涨超7%,凯莱英和方达控股涨超5%,泰格医药和金斯瑞涨近5%,昭衍新药涨超3%。消息面上,盘前有传言称,涉及药明生物和药明康德的HR8333提案在纳入NDAA立法过程中受阻。但有业内分析人士称:“其实药明法案靴子真正落地要看7月到11月的几个流程,昨晚的NDAA大家不是很在意。目前的拉升应该主要还是受益于于位置低,有资金借机尝试去做反弹。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061211385995a70738&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061211385995a70738&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0979878070.USD","LU2039709279.SGD","BK1589","LU0516422952.EUR","02269","688247","01548","688046","BK1141","LU0823426480.USD","600222","BK1521","LU0348825331.USD","LU1242518857.USD","IE00B0JY6N72.USD","LU0359201612.USD","LU0359202008.SGD","688238","BK1610","SG9999002463.SGD","LU0326950275.SGD","LU0708995583.HKD","LU0043850808.USD","LU0516422440.USD","LU0348735423.USD","LU0456827905.SGD","LU0516423091.SGD","688076","LU0307460666.USD","688117","603739","688073","LU0516422366.SGD","LU0572944931.SGD","LU0588546209.SGD","LU1242518931.SGD","LU0417516902.SGD","LU1720050803.USD","LU0417516738.SGD","688265","SG9999002562.SGD","LU0051755006.USD","LU0039217434.USD","LU1688375341.USD","LU1794554557.SGD","LU0181495838.USD","603456","688202","688621","688222","LU0856984785.SGD","LU0327786744.USD","LU0456846285.SGD","LU0516423174.USD","LU0052750758.USD","LU0823426308.USD","LU0320764599.SGD","603127","BK1576","LU0819121731.USD","600721","LU1880383366.USD","688131","LU0140636845.USD"],"gpt_icon":0},{"id":"2442780743","title":"北向资金6月7日净卖出药康生物14.43万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2442780743","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442780743?lang=zh_cn&edition=full","pubTime":"2024-06-11 09:30","pubTimestamp":1718069437,"startTime":"0","endTime":"0","summary":"6月7日,北向资金减持药康生物14.43万股连续5日减持。截止当日收盘,沪股通共持有药康生物145.79万股,占流通股0.71%。沪股通减持金额前五个股分别为贵州茅台、中远海控、伊利股份、恒瑞医药、中国中免。药康生物近5个交易日下跌0.34%,沪股通累计减持57.03万股;近20个交易日下跌7.71%,沪股通累计减持144.22万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061109344995a30490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061109344995a30490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-04-25","address":"江苏省南京市浦口区江北新区学府路12号","stockEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":-0.0616},{"period":"3month","weight":-0.0775},{"period":"6month","weight":-0.4063},{"period":"1year","weight":-0.4273},{"period":"ytd","weight":-0.4859}],"companyName":"江苏集萃药康生物科技股份有限公司","boardCode":"AI0073","perCapita":"25469股","boardName":"研究和试验发展","registeredCapital":"41000万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":" 江苏集萃药康生物科技股份有限公司是一家专业从事实验动物小鼠模型的研发、生产、销售及相关技术服务的高新技术企业,主要产品有商品化小鼠模型销售业务、模型定制业务、定制繁育业务、功能药效业务、代理进出口及其他业务。公司为国内模式动物行业龙头企业之一,是亚洲小鼠突变和资源联盟唯一企业成员、国家科技资源共享服务平台(国家遗传工程小鼠资源库)共建单位,先后被认定为国家级高新技术企业、江苏省博士后创新实践基地、江苏省工程技术研究中心、国家级专精特新小巨人企业等。","serverTime":1721449524103,"listedPrice":22.53,"stockholders":"8007人(较上一季度增加26.31%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药康生物(688046)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药康生物(688046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药康生物,688046,药康生物股票,药康生物股票老虎,药康生物股票老虎国际,药康生物行情,药康生物股票行情,药康生物股价,药康生物股市,药康生物股票价格,药康生物股票交易,药康生物股票购买,药康生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药康生物(688046)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药康生物(688046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}